CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 60 enrolled
Drug / intervention
Experimental Flossdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00855933
NCT00855933Phase 4Completed
CompareCT.gov

A Controlled Clinical Study to Determine the Gingivitis Benefit of Flossing

Procter and Gamble·interventional·Posted Mar 5, 2009·Updated Feb 8, 2013

In Brief

A Phase 4 clinical trial evaluating Experimental Floss for Gingivitis. Completed, enrolled 60 participants across 2 sites in 2 countries.

Detailed Summary

This is a randomized, controlled, examiner-blind, parallel group, four week clinical study comparing brushing plus flossing to brushing alone in healthy adults with mild-to-moderate gingivitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGingivitis
CountriesGuatemala, United States
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 5, 2009
Enrollment StartJan 1, 2009
Primary CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.3 years ago

Interventions

Experimental Flossdevice

Experimental Glide® floss with cetylpyridinium chloride (\~13% dry weight CPC)